SynthesisBMC pregnancy and childbirth2026
The comparative effects of prenatal exposure to methadone versus buprenorphine for opioid use disorder on neonatal outcomes: a systematic review and meta-analysis.
Synthesis in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBoth methadone and buprenorphine are considered safe for use for the treatment of opioid use disorder, but the comparative effectiveness of these regimens during pregnancy has not been well-established. The objective of this systematic review and meta-analysis was to identify and synthesize published evidence from randomized controlled trials and observational studies to evaluate the impacts of methadone and buprenorphine on neonatal health outcomes.
methodsWe searched Medline, Embase, PsycINFO, and CINAHL databases for published randomized controlled trials (RCTs) or observational studies that compared outcomes among individuals who received methadone during pregnancy to individuals who received buprenorphine (with or without naloxone) during pregnancy. Outcomes of interest were preterm birth, low birthweight, small for gestational age, stillbirth, neonatal opioid withdrawal syndrome (NOWS) diagnosis, and NOWS treatment. We conducted separate pooled analyses for the RCTs and observational studies to generate pooled unadjusted risk ratios (RR), 95% confidence intervals (CI), and 95% prediction intervals. Risk of bias was evaluated using the Newcastle Ottawa Scale and the Cochrane Risk-of-Bias-2 tool.
findingsA total of 27 studies (22 observational, 4 RCTs, and one study that included an observational arm and an RCT arm) were included for data extraction and synthesis. The studies included a combined total of 14,978 individuals exposed to buprenorphine and 8,358 individuals exposed to methadone. In the pooled unadjusted analyses of the observational studies, compared with methadone, buprenorphine was associated with lower risk of preterm birth (unadjusted RR 0.63; 95% CI: 0.57-0.70); low birthweight (unadjusted RR 0.48; 95% CI: 0.36-0.64), small for gestational age (unadjusted RR: 0.82; 95% CI 0.77-0.89), and NOWS treatment (unadjusted RR: 0.69; 95% CI: 0.61-0.78). Our findings suggested no difference between groups in terms of NOWS diagnosis or stillbirth, although stillbirth was rare.
conclusionsIn this meta-analysis, exposure to buprenorphine during pregnancy was associated with lower unadjusted risk of several adverse birth outcomes. The quality of the available evidence was limited by a lack of adjustment for key covariates, heterogeneity in the included analyses, and small sample sizes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.